September 22 - 25, 2020 | Sheraton Boston, MA

Submission Form

Clinical Trial Supply: The Quest To Shrink Wastage Levels

Clinical Trial Supply: The Quest To Shrink Wastage Levels

In meeting the growth ahead for clinical trials there must be a focus on efficiency as their supply already suffers from major issues with wastage levels. This is lack of control is problematic with the rising public scrutiny on spending by pharmaceutical companies.

Growth in Demand

The drive to address the diseases that strike the world’s aging population has increased Pharma’s R&D funding. This trend is set to remain, industry estimates state that after seeing lucrative growth in 2016 the clinical trial market size is set to balloon to $65.5 billion in the next eight years.

The supply of these trials is critical. Badly budgeted or scheduled clinical trials can jeopardize the progress made by a candidate.

Clinical trials are incorporating a larger amount of countries than ever before. Although this is positive for producing more representative data and developing products for emerging regions, this globalization does introduce logistical hurdles in terms of supply. Especially with country specific regulations constantly evolving.

Rapid growth seen in emerging markets incurs more supply challenges. Sponsors are expected to provide to trial sites in isolated regions that have limited infrastructure and stubborn climates. 

Striking a Balance

Clinical trials require the production and distribution of investigational pharmaceuticals to thousands of participants over several years.

Sponsors and Clinical Research Organizations (CROs) need to ensure they don’t over supply sites. This excess leads to the wastage of expensive materials, as drugs reach expiry dates before they can be used.

When sites are under supplied, sponsors may have to halt enrolment or even freeze patient treatments. This could have a large influence on the outcomes of a trial. Due to a range of factors, study design, patient enrolment, quantity of sites, site location, that can suddenly change the level of supplies needed for a trial to run, supply managers reduce the risk of stock outs by supplying a surplus of medicine. This in many cases spills over to become overage – when the investigational medicines have to be wasted at the end of a trial or hit their expiry dates before consumption.

Download the full Report below


If you would like a copy of the report sent directly to you, please contact us here.




From Production to Patients: Last Mile Optimization

From Production to Patients: Last Mile Optimization

Though life sciences companies see value across the full supply chain, it’s the last mile that matters the most to the customer. When customers can’t get what they want when they want it due to product loss, theft, spoilage, counterfeiting or other disruptions, it can be incredibly damaging to a company’s brand and bottom line.

Optimizing that last mile involves careful coordination between a complex network of partners, distributors, outsourcers, wholesalers, etc. to ensure the right product reaches the right consumer at the right time. A difficult task for any company but especially so for life sciences companies who’s supply chains are highly regulated and reach a customer base rivaled by few.

With this survey, we aim to demystify the last mile of the pharma supply chain (final packaging to customer delivery) by identifying potential areas of improvement, trending solutions and best practices. Our goal is to provide the industry with new set of benchmarks, data and expert analysis to help accelerate their supply chain optimization journey.


We surveyed 150+ pharma logistics leaders to learn more about the key challenges, solutions and trends impacting the last mile of the life sciences supply chain. Highlights include:

  • Analysis of what causes the most last mile disruptions and how firms are addressing these issues
  • An overview of our respondents top strategic priorities
  • Facts & figures that outline where cold chain leaders are looking to invest on 2018 & 2019


If you would like a copy sent directly to you, please contact us here.




Packaging & Labeling for Life Sciences Ebook

Packaging & Labeling for Life Sciences Ebook

This comprehensive, 75 page ebook contains a curated collection of past presentations, articles + whitepapers that explore that latest thinking when it comes to the packaging, labeling and serialization of life sciences products. Review and enjoy some of our top packaging related content from 2018 such as:

  • 3 Areas Holding Back Optimized Packaging Processes
  • Case Studies on Bulk Reusable Packaging and Real-Time Asset Tracking Technologies 
  • The Case for Fully Standardized Packaging Vendor Qualification Requirements
  • Authentication in pharmaceuticals: a 5-step risk assessment strategy
  • Update on DSCSA and Global Serialization Requirements: Risks and the Go Forward

Includes past presentations by:

  • Jennifer Antonetti, Sr. Supervisor Global Distribution Packaging & Shipping Qualification, Biogen
  • Craig Vermeyen, Senior Manager, Packaging Engineering, Kite Pharma
  • Brian Files, Former Director of Regulatory Compliance & Policy, CVS Health


If you would like a copy of the eBook sent directly to you, please contact us here.




Personalized Medicine & Patient-Centric Supply Chains eBook

Personalized Medicine & Patient-Centric Supply Chains eBook

 As medicine shifts from a “one-size-fits-all” approach to more customized care, patient engagement will become a critical component of supply chain management. In this ebook, we explore the growth of personalized medicine, what it means for life sciences supply chain leaders and how you can jumpstart your journey towards a patient-centric supply chain. Sections include:

  • The rise of personalized medicines and their impact on the supply chain
  • Timing is Everything: Reducing Prescription Abandonment Through Mobile Patient Engagement
  • The Personalized Medicine Supply Chain: Challenges & Solutions
  • Getting Patients Involved in the Cold Chain - 2018 presentation by Alan Kennedy, Founder and Executive Director, PHARMA TEAM-UP

If you would like a copy of the eBook sent directly to you, please contact us here.




Real-Time Temperature Monitoring for Pharma Cold Chain Logistics: 2019 Whitepaper

Real-Time Temperature Monitoring for Pharma Cold Chain Logistics: 2019 Whitepaper

Featuring an article by Nicholas Basta, the Editor in Chief, Managing Partner and Founder of Pharmaceutical Commerce!


When it comes to safely and securely transporting high-value pharmaceutical products, the stakes couldn’t be higher. Not only is a single consignment of high-value drugs potentially worth upwards of $50 million, but, for those patients in need of these drugs, ensuring these products arrive on time and in optimal condition is quite literally a matter of life and death.

Historically, life science manufacturers have lacked the tools, resources, and technology necessary to gain full visibility into the environmental conditions their products are stored in as they traveled through the cold chain. Because data loggers only provided temperature data once the shipment had arrived at its final destination if a temperature excursion did occur, cold chain leaders could only find out after the fact. In fact, according to a 2014 study by IMS Health, the top 10 pharmaceutical companies lost an average of  $16 billion worth of product (20X the average pharma company’s price-to-earnings ratio) each year due to transportation problems, the resulting temperature excursions and other delays. For the entire pharmaceutical industry, losses exceeded $35 billion (1).

However, recent technological advancements in IoT, data management tools and connectivity have ushered in a new era of real-time temperature monitoring. Due to the emergence of better, faster and more accurate real-time monitoring tools, life sciences manufacturers can now track high-value products in real-time to ensure safe and on-time delivery.

In PART I of this whitepaper, Nick Basta of Pharmaceutical Commerce provides an overview of the evolution of real-time monitoring solutions.

PART II explores the business benefits of real-time, temperature monitoring solutions and best practices for implementations. The ideas, challenges, and solutions covered in the section were pulled from in-depth interviews with our expert speaker faculty.


If you would like a copy sent directly to you, please contact us here.



Blockchain Adoption in Pharma Supply

Blockchain Adoption in Pharma Supply

Experts have asserted that despite recent developments, pharmaceutical supply chains are still far from reaching their full technological potential. However, Blockchain holds significant promise to advance the digital strength of medicine supply. In this whitepaper, we explore:

  • What is blockchain and how can it be applied to cold chain?
  • Who in life sciences is currently using blockchain and for what?
  • How will the emergence of blockchain impact the industry over the next decade?

Plus! We provide an overview of potential use cases for block chain such as:

  • Leveraging R&D data for collaborative research
  • Dynamic pricing managed for raw materials
  • Compliance and quality tracking
  • Pharmacovigilance reporting
  • Temperature control
  • Temperature monitoring and control


If you would like a copy of the article sent directly to you, please contact us here.